Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Albrecht, K., Englbrecht, M., Baerwald, C., Feist, E., Fleck, M., Gromnica-Ihle, E., Koehler, L., Koetter, I., Kneitz, C., Krueger, K., Kuipers, J., Nuesslein, H., Rubbert-Roth, A., Wollenhaupt, J., Schneider, M., Manger, B., Mueller-Ladner, U. and Tarner, I. H. (2015). National and Multinational Evidence-based Recommendations for Medical Pain Management in Inflammatory Joint Disease: Systematic Literature Research and Expert Opinion in the 3e Initiative. Aktuelle Rheumatol., 40 (1). S. 67 - 77. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-9940

Doerner, T., Schulze-Koops, H., Burmester, G. -R., Iking-Konert, C., Schmalzing, M., Engel, A., Kaestner, P., Kellner, H., Kurthen, R., Krueger, K., Rubbert-Roth, A., Schwenke, H., Peters, M. A. and Tony, H. -P. (2019). Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI). Clin. Exp. Rheumatol., 37 (6). S. 937 - 946. PISA: CLINICAL & EXPER RHEUMATOLOGY. ISSN 1593-098X

Kalden, J., Burkhardt, H., Buss, B., Donhauser-Gruber, U., Erstling, U., Gromnica-Ihle, E., Karberg, K., Karger, T., Kneitz, Ch., Krause, A., Krueger, K., Lorenz, H-M., Mueller-Ladner, U., Rubbert-Roth, A., Steffens-Korbanka, P., Tony, H. -P., Wendler, J., Wollenhaupt, J. and Burmester, G. (2011). Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis. Z. Rheumatol., 70 (8). S. 641 - 650. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250

Koehm, M., Rossmanith, T., Dauth, S., Alten, R., Aringer, M., Backhaus, M., Burmester, G., Feist, E., Kellner, H., Krueger, K., Mueller-Ladner, U., Rubbert-Roth, A., Tony, H-P., Wassenberg, S., Burkhardt, H. and Behrens, F. (2017). IMPACT OF RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE AND RITUXIMAB RETREATMENT WITH TWO DIFFERENT DOSAGES ON PATIENT-REPORTED OUTCOMES: RESULTS FROM A MULTICENTER RANDOMIZED PLACEBO CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY). Ann. Rheum. Dis., 76. S. 565 - 566. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

Tarner, I. H., Albrecht, K., Fleck, M., Gromnica-Ihle, E., Keysser, G., Koehler, L., Koetter, I., Krueger, K., Kuipers, J., Nuesslein, H., Rubbert-Roth, A., Wollenhaupt, J., Schneider, M., Manger, B. and Mueller-Ladner, U. (2014). Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative. Z. Rheumatol., 73 (4). S. 363 - 374. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250

This list was generated on Tue Apr 16 13:53:56 2024 CEST.